太平洋给予司太立“买入”评级：造影剂一体化头部供应商，产能投放驱动成长

Group 1 - The core viewpoint of the article is that Pacific Securities has issued a "buy" rating for Sital (603520.SH) with a latest price of 11.43 yuan, highlighting its strong market position and growth potential [1] - Sital is recognized as a leading enterprise in the integrated production of iodine contrast agents, with a steady advancement in its internationalization strategy [1] - The company is expected to improve its profitability due to the expansion of its active pharmaceutical ingredient (API) production capacity and various factors driving growth [1] - Sital is overcoming production capacity bottlenecks in its formulations, which will drive growth both domestically and internationally [1]